Currently Vice President of Biostatistics & Data Management for Genomic Health, Dr. Whitmore oversees support of genomics-based diagnostic tests that address early-stage cancer. Previously with Juno Therapeutics as Vice President of Biometrics for Juno Therapeutics, Dr. Whitmore oversaw support of cellular immunotherapy products in hematologic oncology, including biostatistics, statistical programming and data management. Dr. Whitmore earned his MS and PhD in Statistics from Colorado State University.